Antiplasmin - The forgotten serpin?

被引:46
作者
Coughlin, PB [1 ]
机构
[1] Monash Univ, Australian Ctr Blood Dis, Prahran, Vic 3181, Australia
关键词
antiplasmin; fibrinolysis; plasminogen; serpinF2;
D O I
10.1111/j.1742-4658.2005.04881.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Much of the basic biochemistry of antiplasmin was described more than 20 years ago and yet it remains an enigmatic member of the serine protease inhibitor (serpin) family. It possesses all of the characteristics of other inhibitory serpins but in addition it has unique N- and C-terminal extensions which significantly modify its activities. The N-terminus serves as a substrate for Factor XIIIa leading to crosslinking and incorporation of antiplasmin into a clot as it is formed. Although free antiplasmin is an excellent inhibitor of plasmin, the fibrin bound form of the serpin appears to be the major regulator of clot lysis. The C-terminal portion of antiplasmin is highly conserved between species and contains several charged amino acids including four lysines with one of these at the C-terminus. This portion of the molecule mediates the initial interaction with plasmin and is a key component of antiplasmin's rapid and efficient inhibitory mechanism. Studies of mice with targeted deletion of antiplasmin have confirmed its importance as a major regulator of fibrinolysis and re-emphasized its value as a potential therapeutic target.
引用
收藏
页码:4852 / 4857
页数:6
相关论文
共 33 条
[1]  
Bateman J B, 1986, J Pediatr Ophthalmol Strabismus, V23, P137
[2]   Molecular analysis of blood vessel formation and disease [J].
Carmeliet, P ;
Collen, D .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (05) :H2091-H2104
[3]   Assignment of a single disulphide bridge in human alpha(2)-antiplasmin: Implications for the structural and functional properties [J].
Christensen, S ;
Valnickova, Z ;
Thogersen, IB ;
Olsen, EHN ;
Enghild, JJ .
BIOCHEMICAL JOURNAL, 1997, 323 :847-852
[4]   Congenital α2-plasmin inhibitor deficiencies:: a review [J].
Favier, R ;
Aoki, N ;
de Moerloose, P .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) :4-10
[5]   Structural/functional characterization of the α2-plasmin inhibitor C-terminal peptide [J].
Frank, PS ;
Douglas, JT ;
Locher, M ;
Llinás, M ;
Schaller, J .
BIOCHEMISTRY, 2003, 42 (04) :1078-1085
[6]   ORGANIZATION OF THE HUMAN ALPHA-2-PLASMIN INHIBITOR GENE [J].
HIROSAWA, S ;
NAKAMURA, Y ;
MIURA, O ;
SUMI, Y ;
AOKI, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6836-6840
[7]   ALPHA-2-ANTIPLASMIN ENSCHEDE - ALANINE INSERTION AND ABOLITION OF PLASMIN INHIBITORY ACTIVITY [J].
HOLMES, WE ;
LIJNEN, HR ;
NELLES, L ;
KLUFT, C ;
NIEUWENHUIS, HK ;
RIJKEN, DC ;
COLLEN, D .
SCIENCE, 1987, 238 (4824) :209-211
[8]   Phylogeny of the serpin superfamily: Implications of patterns of amino acid conservation for structure and function [J].
Irving, JA ;
Pike, RN ;
Lesk, AM ;
Whisstock, JC .
GENOME RESEARCH, 2000, 10 (12) :1845-1864
[9]  
KIMURA S, 1985, BLOOD, V66, P157
[10]   ALPHA-2-ANTIPLASMIN ENSCHEDE - DYSFUNCTIONAL ALPHA-2-ANTIPLASMIN MOLECULE ASSOCIATED WITH AN AUTOSOMAL RECESSIVE HEMORRHAGIC DISORDER [J].
KLUFT, C ;
NIEUWENHUIS, HK ;
RIJKEN, DC ;
GROENEVELD, E ;
WIJNGAARDS, G ;
VANBERKEL, W ;
DOOIJEWAARD, G ;
SIXMA, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (05) :1391-1400